Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/12/1996 | CN1124162A Weight increasing agent for animals and poultry |
06/12/1996 | CN1124142A Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
06/12/1996 | CN1124110A Nutritive liquor for pregnant woman and its preparing method |
06/12/1996 | CN1032019C Process for recombinant biocides using organisms |
06/11/1996 | US5525727 Brain-specific drug delivery |
06/11/1996 | US5525723 Inhibitors of angiotensin converting enzyme, neutral endopeptidase |
06/11/1996 | US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells |
06/11/1996 | US5525705 Regulate fat tissue |
06/11/1996 | US5525628 Salts of a glutathione alkylester and anaminoacids |
06/11/1996 | US5525623 Compositions and methods for the treatment of immunomediated inflammatory disorders |
06/11/1996 | US5525593 Used for regeneration of muscle tissue, minimizing scar formation during healing of wound |
06/11/1996 | US5525590 Immunosuppressants, antiinflammatory and antiparasitic |
06/11/1996 | US5525513 Isolated mammalian dna sequence which hybridizes to specified primers |
06/11/1996 | US5525508 Purified antigen derived from homogenizing nematodes, extracting and chromatographing on wheat-germ lectin sepharose column |
06/11/1996 | US5525488 Nonchromosomal dna encoding inhibin alpha chain polypeptide having specified sequence |
06/11/1996 | US5525487 DNA encoding I-CAM related protein |
06/11/1996 | US5525486 Genetic engineering |
06/11/1996 | US5525472 Mixing neutralized fatty acids, triglycerides or monoglycerides into escherichia cultures, then cell lysis in presence of magnesium ions and treatment of insoluble recovered material with nonionic detergents |
06/11/1996 | US5525468 Assay for Ribozyme target site |
06/11/1996 | US5525349 Before and after eye surgery treatment applying a steroid antiinflammatory agent, microbiocides |
06/11/1996 | US5525338 Detection and therapy of lesions with biotin/avidin conjugates |
06/11/1996 | US5525337 Detecting tumor cells by removing tissue or fluid sample, reacting with antibody capable of binding to surface antigen, detecting presence of antibody-antigen complex |
06/11/1996 | US5525335 Wound healing agent |
06/11/1996 | EP0722489A4 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
06/11/1996 | CA2164766A1 Process for the inactivation of viruses with the aid of acridine or acridine derivatives |
06/11/1996 | CA2005950C Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein |
06/11/1996 | CA1338395C Pharmaceutical containing tissue protein pp4, a process for the pasteurization of pp4, and the use of pp4 |
06/11/1996 | CA1338381C Minactivin - (plasminogen activator inhibitor-2) |
06/10/1996 | CA2158116A1 Method for inducing superovulation in cattle |
06/07/1996 | WO1996017869A2 Interleukin-6 (il-6) antagonists |
06/07/1996 | CA2177837A1 Interleukin-6 (il-6) antagonists |
06/07/1996 | CA2141708A1 Nucleotide sequences encoding a novel stem cell marker protein, amino acid sequences of the protein, methods for expressing the protein, a composition of isolated protein, and antibodies specific to the protein |
06/06/1996 | WO1996017078A1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
06/06/1996 | WO1996017074A2 Rna polymerase ii peptides and methods of use |
06/06/1996 | WO1996017072A2 Recombinant alphavirus vectors |
06/06/1996 | WO1996017070A1 Method of preparing a viral vector by homologous intermolecular recombination |
06/06/1996 | WO1996017064A1 Phenylalanine free proteins |
06/06/1996 | WO1996017063A1 Plasmids suitable for il-2 expression |
06/06/1996 | WO1996017062A1 Low molecular weight thrombopoietin |
06/06/1996 | WO1996017061A1 An sh3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof |
06/06/1996 | WO1996017060A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
06/06/1996 | WO1996017059A2 Receptor for cell-binding domain of thrombospondins |
06/06/1996 | WO1996017058A1 Denatured low-density lipoprotein receptor |
06/06/1996 | WO1996017057A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
06/06/1996 | WO1996017056A1 Hypermutagenesis |
06/06/1996 | WO1996017054A1 Method and compositions for reducing cholesterol absorption |
06/06/1996 | WO1996017053A1 Vectors for tissue-specific replication |
06/06/1996 | WO1996016990A1 Humanized antibodies to cd38 |
06/06/1996 | WO1996016989A1 p53 PROTEINS WITH ALTERED TETRAMERIZATION DOMAINS |
06/06/1996 | WO1996016987A1 Thrombocytotic factor |
06/06/1996 | WO1996016986A1 Mel-cam ligand and its use |
06/06/1996 | WO1996016983A1 Cooperative combinations of ligands contained within a matrix |
06/06/1996 | WO1996016982A2 Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
06/06/1996 | WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
06/06/1996 | WO1996016977A1 Novel anti-hiv agent |
06/06/1996 | WO1996016976A1 Antisense oligonucleotide and carcinostatic agent containing the same |
06/06/1996 | WO1996016950A1 Hiv protease inhibitors |
06/06/1996 | WO1996016947A1 Novel 2,3-diketopiperazine derivative or salt thereof |
06/06/1996 | WO1996016715A1 Centrifuge with annular filter |
06/06/1996 | WO1996016714A1 Method and device for separating fibrin monomer from blood plasma |
06/06/1996 | WO1996016680A1 Phosphocholine drug derivatives |
06/06/1996 | WO1996016676A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
06/06/1996 | WO1996016674A1 In vitro t-lymphopoiesis system |
06/06/1996 | WO1996016673A1 Method of promoting an immune response with a bispecific antibody |
06/06/1996 | WO1996016671A1 New antithrombotic formulation, process for its manufacturing, and use thereof |
06/06/1996 | WO1996016670A1 New therapeutical utilization of superoxide dismutases |
06/06/1996 | WO1996016669A1 Use of human recombinant epidermal growth factor in the manufacture of a medicament for treating acne |
06/06/1996 | WO1996016668A1 Novel hedgehog-derived polypeptides |
06/06/1996 | WO1996016665A1 Cd40 associated proteins |
06/06/1996 | WO1996016662A1 Growth factor expression in human pregnant cervix |
06/06/1996 | WO1996016645A1 Use of nitric oxide donors in medicine |
06/06/1996 | WO1996016546A1 Germicidal detergent-iodine compositions including polyvinyl pyrrolidone and compatible nonionic surfactant complexors |
06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
06/06/1996 | WO1995032298A3 Safe vectors for gene therapy |
06/06/1996 | CA2207869A1 Method of promoting an immune response with a bispecific antibody |
06/06/1996 | CA2206610A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
06/06/1996 | CA2206553A1 Receptor for cell-binding domain of thrombospondins |
06/06/1996 | CA2206527A1 Growth factor expression in human pregnant cervix |
06/06/1996 | CA2206526A1 Method and compositions for reducing cholesterol absorption |
06/06/1996 | CA2206496A1 Thrombocytotic factor |
06/06/1996 | CA2206459A1 New antithrombotic formulation, process for its manufacturing, and use thereof |
06/06/1996 | CA2206449A1 In vitro t-lymphopoiesis system |
06/06/1996 | CA2206441A1 Cd40 associated proteins |
06/06/1996 | CA2206305A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
06/06/1996 | CA2206205A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
06/06/1996 | CA2206175A1 Cooperative combinations of ligands contained within a matrix |
06/06/1996 | CA2206142A1 New therapeutical utilization of superoxide dismutases |
06/06/1996 | CA2206053A1 Novel 2,3-diketopiperazine derivatives or their salts |
06/06/1996 | CA2204902A1 Phosphocholine drug derivatives |
06/05/1996 | EP0714982A2 Hybrid proteins with fibrinolytic and thrombin inhibiting activity |
06/05/1996 | EP0714981A2 PRLTS proteins and DNA's encoding the same |
06/05/1996 | EP0714980A1 Hypermutagenesis |
06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
06/05/1996 | EP0714911A2 Somastotatin analogs containing chelating groups and their radiolabeled compositions |
06/05/1996 | EP0714910A1 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements |
06/05/1996 | EP0714909A1 Composition for prophylaxis or treatment of pulmonary circulatory diseases |
06/05/1996 | EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors |
06/05/1996 | EP0714665A2 Osteogenic devices |
06/05/1996 | EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles |
06/05/1996 | EP0714511A1 Methods of detecting and combating disorders of the central nervous system |